Demand is high for Eli Lilly’s Zepbound, and the weight-loss drug market could reach $100 billion by the end of the decade.
But one thing is getting in between some potential patients and this promising drug.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,